Balance Sheet M1 Kliniken AG Deutsche Boerse AG

Stocks

M12

DE000A0STSQ8

Healthcare Facilities & Services

Real-time Estimate Tradegate Other stock markets 11:35:26 2026-06-11 am EDT			5-day change	1st Jan Change
17.88 ^EUR	-2.08%		-2.17%	+1.12%

May. 26	M1 Kliniken Finalizes Capital Reduction via Treasury Shares Cancellation	MT
May. 20	M1 Kliniken AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI

d6edb56cbcbb14e3728964d.Ntxi5GF33RpWFWyw1lvhkU7hYh8wE17o5TxRlwnQtiI.VKs2rCxAmVk_by72mCiE_wGFN1dgeAyYomU1_HqhxHFwmyS8GEWITxJwHw

Published financial data: M1 KLINIKEN AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	315M	285M	316M	339M	364M
Total Revenues	315M	285M	316M	339M	364M
Cost of Goods Sold, Total	282M	254M	284M	296M	311M
Gross Profit	32.72M	31.23M	32.47M	43.42M	52.92M
Selling General & Admin Expenses, Total	1.67M	1.66M	1.98M	2.34M	1.88M
Depreciation & Amortization - (IS)	5.69M	6.06M	5.31M	5.21M	4.88M
Other Operating Expenses	13.23M	14.57M	10.54M	9.81M	11.97M
Other Operating Expenses, Total	20.59M	22.29M	17.83M	17.37M	18.73M
Operating Income	12.14M	8.94M	14.64M	26.05M	34.19M
Interest Expense, Total	-917K	-828K	-1.35M	-1.93M	-1.54M
Interest And Investment Income	667K	1.5M	2.1M	990K	1.04M
Net Interest Expenses	-249K	668K	748K	-937K	-499K
Income (Loss) On Equity Invest.	1.21M	-	-	-	-
Currency Exchange Gains (Loss)	-296K	-68.54K	-66.55K	226K	37.85K
Other Non Operating Income (Expenses)	44.1K	263K	7.69K	372K	180K
EBT, Excl. Unusual Items	12.84M	9.81M	15.33M	25.71M	33.91M
Gain (Loss) On Sale Of Investments	1.33M	218K	-2K	482K	-
Gain (Loss) On Sale Of Assets	12.82K	12.28K	969K	66.44K	128K
Insurance Settlements	238K	196K	146K	36.96K	27.89K
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	14.42M	10.23M	16.45M	26.3M	34.06M
Income Tax Expense	3.54M	3.16M	4.78M	8.51M	9.96M
Earnings From Continuing Operations	10.88M	7.07M	11.67M	17.79M	24.1M
Net Income to Company	10.88M	7.07M	11.67M	17.79M	24.1M
Minority Interest	-1.97M	-2.75M	-1.39M	-1.77M	-1.97M
Net Income - (IS)	8.91M	4.32M	10.27M	16.02M	22.13M
Net Income to Common Incl Extra Items	8.91M	4.32M	10.27M	16.02M	22.13M
Net Income to Common Excl. Extra Items	8.91M	4.32M	10.27M	16.02M	22.13M
Per Share Items
Net EPS - Basic	0.48	0.24	0.54	0.85	1.19
Basic EPS - Continuing Operations	0.48	0.24	0.54	0.85	1.19
Basic Weighted Average Shares Outstanding	18.58M	18.32M	19.13M	18.78M	18.56M
Net EPS - Diluted	0.48	0.24	0.54	0.85	1.19
Diluted EPS - Continuing Operations	0.48	0.24	0.54	0.85	1.19
Diluted Weighted Average Shares Outstanding	18.58M	18.32M	19.13M	18.78M	18.56M
Normalized Basic EPS	0.33	0.18	0.43	0.76	1.04
Normalized Diluted EPS	0.33	0.18	0.43	0.76	1.04
Dividend Per Share	-	-	0.5	0.5	1.2
Payout Ratio	18.62	42.24	19.28	58.12	42.06
Supplemental Items
EBITDA	14.13M	10.6M	17.93M	27.45M	35.38M
EBITA	13.2M	9.64M	15.27M	26.7M	34.69M
EBIT	12.14M	8.94M	14.64M	26.05M	34.19M
EBITDAR	15.8M	12.26M	19.91M	29.79M	37.26M
Effective Tax Rate - (Ratio)	24.57	30.91	29.06	32.35	29.25
Total Current Taxes	1.53M	1.41M	3.97M	5.28M	7.02M
Total Deferred Taxes	837K	776K	-1.23M	834K	67.92K
Normalized Net Income	6.05M	3.38M	8.19M	14.3M	19.22M
Interest on Long-Term Debt	410K	427K	414K	373K	338K
Supplemental Operating Expense Items
Net Rental Expense, Total	1.67M	1.66M	1.98M	2.34M	1.88M
Imputed Operating Lease Interest Expense	351K	441K	1.2M	1.94M	1.48M
Imputed Operating Lease Depreciation	1.32M	1.22M	773K	407K	405K
Maintenance & Repair Expenses, Total	451K	601K	395K	288K	382K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	37.87M	35.15M	22.38M	21.43M	37.76M
Short Term Investments	15.73M	12.35M	375K	330K	4.24M
Total Cash And Short Term Investments	53.6M	47.5M	22.76M	21.76M	42M
Accounts Receivable, Total	16.31M	21.77M	28.02M	16.41M	6.33M
Other Receivables	2.51M	5.46M	8.04M	6.28M	2.4M
Notes Receivable	2.07M	-	-	-	-
Total Receivables	20.88M	27.23M	36.06M	22.69M	8.74M
Inventory	35.2M	27.59M	45.53M	36.79M	31.81M
Prepaid Expenses	-	302K	-	-	-
Other Current Assets, Total	512K	4.69M	6.25M	2.31M	6.79M
Total Current Assets	110M	107M	111M	83.55M	89.33M
Gross Property Plant And Equipment	32.34M	36.44M	35.9M	37.82M	36.98M
Accumulated Depreciation	-17.07M	-19.27M	-22.11M	-24.92M	-27.57M
Net Property Plant And Equipment	15.27M	17.18M	13.79M	12.9M	9.41M
Long-term Investments	12M	12M	939K	3.63M	781
Goodwill	34.33M	34.3M	62.13M	62.09M	64.69M
Other Intangibles, Total	25.46M	25.01M	24.7M	24.83M	24.95M
Other Long-Term Assets, Total	850K	1.23M	809K	866K	899K
Total Assets	198M	197M	213M	188M	189M
Liabilities
Accounts Payable, Total	12.84M	19.22M	33.26M	12.97M	8.44M
Accrued Expenses, Total	571K	5.27M	6.02M	5.26M	4.88M
Current Portion of Long-Term Debt	14.53M	2.38M	3.53M	10.7M	3.11M
Current Portion of Leases	3.66M	3.38M	2.97M	3.13M	2.1M
Current Income Taxes Payable	1.92M	2.67M	5.89M	6.9M	4.89M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	9.9M	4.54M	6.59M	4.79M	8.27M
Total Current Liabilities	43.42M	37.47M	58.25M	43.75M	31.68M
Long-Term Debt	4.38M	3.12M	1.88M	-	-
Long-Term Leases	8.13M	10.32M	7.82M	7.28M	5.05M
Deferred Tax Liability Non Current	2.23M	3M	1.77M	2.61M	2.54M
Other Non Current Liabilities	59.78K	54.39K	11.01K	11.01K	11.01K
Total Liabilities	58.21M	53.97M	69.73M	53.65M	39.28M
Common Stock, Total	19.64M	19.64M	19.64M	19.64M	19.64M
Retained Earnings	37.39M	38M	50.12M	57.28M	69.91M
Treasury Stock	-11.81M	-13.95M	-6.37M	-20.81M	-20.81M
Comprehensive Income and Other	49.79M	99.36M	49.86M	49.99M	51.19M
Total Common Equity	95.03M	143M	113M	106M	120M
Minority Interest	44.88M	-	29.97M	28.12M	30.09M
Total Equity	140M	143M	143M	134M	150M
Total Liabilities And Equity	198M	197M	213M	188M	189M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18.58M	18.32M	18.32M	18.88M	18.66M
ECS Total Common Shares Outstanding	18.58M	18.32M	18.32M	18.88M	18.66M
Book Value / Share	5.11	7.81	6.18	5.62	6.43
Tangible Book Value	35.23M	83.74M	26.43M	19.17M	30.29M
Tangible Book Value Per Share	1.9	4.57	1.44	1.02	1.62
Total Debt	30.69M	19.2M	16.19M	21.12M	10.26M
Net Debt	-22.91M	-28.29M	-6.56M	-646K	-31.74M
Debt Equivalent Oper. Leases	13.35M	13.28M	15.81M	18.75M	15.07M
Minority Interest, Total (Incl. Fin. Div)	44.88M	-	29.97M	28.12M	30.09M
Equity Method Investments, Total	12M	12M	939K	3.63M	781
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Finished Goods, Total	34.79M	26.91M	45.27M	36.13M	31.76M
Inventories - Others	410K	678K	256K	658K	45.22K
Land - (BS)	-	2.56M	2.56M	2.56M	2.56M
Machinery, Total	9.32M	9.67M	10.01M	10.21M	10.59M
Full Time Employees	350	366	219	199	280

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	8.91M	4.32M	10.27M	16.02M	22.13M
Depreciation & Amortization - CF	4.29M	5.16M	4.68M	4.51M	4.38M
Amortization of Goodwill and Intangible Assets - (CF)	1.06M	700K	630K	646K	505K
Depreciation & Amortization, Total	5.35M	5.86M	5.31M	5.16M	4.88M
Amortization of Deferred Charges, Total - (CF)	291K	-	-	-	-
(Gain) Loss From Sale Of Asset	56.62K	125K	-35.46K	11.41K	992K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	4.72M	3.1M	1.11M	7.5M	3.09M
Change In Accounts Receivable	-10.29M	-4.38M	5.18M	13.64M	2.84M
Change In Inventories	7.13M	7.6M	-17.18M	8.72M	11.77M
Change In Accounts Payable	-	4.97M	1.02M	-20.2M	-7.95M
Change in Other Net Operating Assets	-483K	-823K	2.14M	-296K	189K
Cash from Operations	15.68M	20.77M	7.81M	30.55M	37.95M
Capital Expenditure	-1.03M	-1.16M	-455K	-228K	-110K
Sale of Property, Plant, and Equipment	176K	73.47K	49.43K	8.25K	58.77K
Cash Acquisitions	-	-71.48K	-	-	-
Divestitures	1.08M	-	-	-	-
Sale (Purchase) of Intangible assets	-303K	-610K	-555K	-768K	125K
Investment in Marketable and Equity Securities, Total	-120	-	-10.4M	-5.54M	321K
Other Investing Activities, Total	287K	654K	2M	861K	-3.99M
Cash from Investing	213K	-1.12M	-9.36M	-5.67M	-3.59M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-8.29M	-18M	-28.9M	-4.14M	-4.1M
Total Debt Repaid	-8.29M	-18M	-28.9M	-4.14M	-4.1M
Issuance of Common Stock	2.01M	-	7.58M	-	-
Repurchase of Common Stock	-	-2.15M	-3.63M	-15.46M	-5
Common Dividends Paid	-1.66M	-1.82M	-1.98M	-9.31M	-9.31M
Common & Preferred Stock Dividends Paid	-1.66M	-1.82M	-1.98M	-9.31M	-9.31M
Other Financing Activities, Total	11.97M	-399K	-888K	-1.53M	-1.2M
Cash from Financing	4.03M	-22.37M	-27.82M	-30.44M	-14.61M
Foreign Exchange Rate Adjustments	-13.67K	-5.94K	72.46K	-97.96K	60.69K
Miscellaneous Cash Flow Adjustments	-	1	13.01M	-	2.39M
Net Change in Cash	19.91M	-2.72M	-16.29M	-5.66M	22.19M
Supplemental Items
Cash Interest Paid	506K	399K	888K	1.53M	1.2M
Cash Income Tax Paid (Refund)	29.99K	2.16M	4.38M	5.91M	9.28M
Levered Free Cash Flow	35.47M	16.91M	4.63M	23.45M	36.31M
Unlevered Free Cash Flow	36.04M	17.43M	5.47M	24.66M	37.28M
Change In Net Working Capital	-24.14M	-7.75M	7.98M	-4.21M	-11.01M
Net Debt Issued / Repaid	-8.29M	-18M	-28.9M	-4.14M	-4.1M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.92	2.83	4.46	8.12	11.33
Return on Total Capital	4.67	3.36	5.69	10.35	13.54
Return On Equity %	8.53	5	8.15	12.83	16.96
Return on Common Equity	9.85	3.05	9.84	14.61	19.58
Margin Analysis
Gross Profit Margin %	10.4	10.95	10.27	12.8	14.53
SG&A Margin	0.53	0.58	0.62	0.69	0.52
EBITDA Margin %	4.49	3.71	5.67	8.09	9.71
EBITA Margin %	4.2	3.38	4.83	7.87	9.52
EBIT Margin %	3.86	3.14	4.63	7.68	9.38
Income From Continuing Operations Margin %	3.46	2.48	3.69	5.25	6.62
Net Income Margin %	2.83	1.51	3.25	4.72	6.08
Net Avail. For Common Margin %	2.83	1.51	3.25	4.72	6.08
Normalized Net Income Margin	1.92	1.18	2.59	4.22	5.28
Levered Free Cash Flow Margin	11.27	5.93	1.46	6.91	9.97
Unlevered Free Cash Flow Margin	11.46	6.11	1.73	7.27	10.23
Asset Turnover
Asset Turnover	1.63	1.44	1.54	1.69	1.93
Fixed Assets Turnover	20.28	17.59	20.43	25.41	32.65
Receivables Turnover (Average Receivables)	17.1	14.98	12.71	15.27	32.03
Inventory Turnover (Average Inventory)	7.27	8.09	7.76	7.19	9.08
Short Term Liquidity
Current Ratio	2.54	2.86	1.9	1.91	2.82
Quick Ratio	1.67	1.99	1.01	1.02	1.6
Operating Cash Flow to Current Liabilities	0.36	0.55	0.13	0.7	1.2
Days Sales Outstanding (Average Receivables)	21.34	24.36	28.73	23.97	11.4
Days Outstanding Inventory (Average Inventory)	50.19	45.1	47.01	50.93	40.21
Average Days Payable Outstanding	19.05	23.75	31.73	29.47	12.75
Cash Conversion Cycle (Average Days)	52.48	45.72	44	45.43	38.85
Long Term Solvency
Total Debt/Equity	21.94	13.42	11.31	15.73	6.84
Total Debt / Total Capital	17.99	11.84	10.16	13.6	6.4
LT Debt/Equity	8.94	9.4	6.77	5.43	3.36
Long-Term Debt / Total Capital	7.33	8.29	6.08	4.69	3.15
Total Liabilities / Total Assets	29.38	27.39	32.74	28.56	20.75
EBIT / Interest Expense	13.24	10.8	10.87	13.52	22.21
EBITDA / Interest Expense	19.08	17.88	14.81	16.2	25.38
(EBITDA - Capex) / Interest Expense	17.96	16.48	14.48	16.08	25.31
Total Debt / EBITDA	1.75	1.3	0.81	0.68	0.26
Net Debt / EBITDA	-1.31	-1.91	-0.33	-0.02	-0.81
Total Debt / (EBITDA - Capex)	1.86	1.41	0.83	0.68	0.26
Net Debt / (EBITDA - Capex)	-1.39	-2.07	-0.34	-0.02	-0.81
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	97.14	-9.32	10.88	7.23	7.4
Gross Profit, 1 Yr. Growth %	65.29	-4.56	3.97	33.71	21.88
EBITDA, 1 Yr. Growth %	146.99	-26.53	69.24	62.27	30.33
EBITA, 1 Yr. Growth %	185.9	-28.56	58.37	66.62	31.44
EBIT, 1 Yr. Growth %	175.89	-26.3	63.72	69.53	32.78
Earnings From Cont. Operations, 1 Yr. Growth %	46.53	-35.02	65.02	52.5	35.45
Net Income, 1 Yr. Growth %	30.52	-51.52	137.98	55.91	38.17
Normalized Net Income, 1 Yr. Growth %	103.02	-44.2	142.56	65.41	34.46
Diluted EPS Before Extra, 1 Yr. Growth %	30.54	-50.82	127.89	58.79	38.17
Accounts Receivable, 1 Yr. Growth %	-20.37	33.51	28.69	-41.42	-61.4
Inventory, 1 Yr. Growth %	-16.83	-21.64	65.03	-19.19	-13.55
Net Property, Plant and Equip., 1 Yr. Growth %	-3.14	12.51	-19.7	-6.47	-27.02
Total Assets, 1 Yr. Growth %	4.96	-0.55	8.08	-11.78	0.75
Tangible Book Value, 1 Yr. Growth %	-25.72	4.54	-27.02	-27.44	57.95
Common Equity, 1 Yr. Growth %	10.81	2.25	18.56	-6.31	13.03
Cash From Operations, 1 Yr. Growth %	64.4	32.41	-62.4	291.14	24.24
Capital Expenditures, 1 Yr. Growth %	13.29	13.15	-60.87	-49.98	-85.64
Levered Free Cash Flow, 1 Yr. Growth %	-245.29	-45.41	-72.63	361.56	54.6
Unlevered Free Cash Flow, 1 Yr. Growth %	-250.42	-44.76	-68.61	316.28	50.96
Dividend Per Share, 1 Yr. Growth %	-	-	-	0	140
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	101.85	33.7	0.27	9.04	7.32
Gross Profit, 2 Yr. CAGR %	31.3	25.6	-0.38	17.91	27.66
EBITDA, 2 Yr. CAGR %	24.71	36.09	11.51	60.95	44.62
EBITA, 2 Yr. CAGR %	29.96	44.53	6.37	66.38	47.14
EBIT, 2 Yr. CAGR %	24.64	42.59	9.85	70.67	49.15
Earnings From Cont. Operations, 2 Yr. CAGR %	5.75	-2.42	3.55	58.64	43.72
Net Income, 2 Yr. CAGR %	-4.33	-20.45	7.41	92.62	46.77
Normalized Net Income, 2 Yr. CAGR %	1.65	6.44	16.34	105.77	49.14
Diluted EPS Before Extra, 2 Yr. CAGR %	-7.15	-19.87	5.87	90.23	49.01
Accounts Receivable, 2 Yr. CAGR %	-14.37	3.11	31.08	-13.18	-52.45
Inventory, 2 Yr. CAGR %	381.31	-19.27	13.72	15.49	-16.41
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.29	4.39	-4.95	-13.34	-17.38
Total Assets, 2 Yr. CAGR %	46.1	2.17	3.68	-2.35	-5.72
Tangible Book Value, 2 Yr. CAGR %	-23.22	32.88	-42.56	-27.23	7.05
Common Equity, 2 Yr. CAGR %	18.02	29.16	-10.03	5.39	2.91
Cash From Operations, 2 Yr. CAGR %	70.9	47.54	-29.44	21.27	120.44
Capital Expenditures, 2 Yr. CAGR %	-1.73	13.22	-33.46	-55.76	-50.78
Levered Free Cash Flow, 2 Yr. CAGR %	154.86	-16.77	-61.35	17.76	167.33
Unlevered Free Cash Flow, 2 Yr. CAGR %	162.1	-14.71	-58.36	18.94	150.86
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	54.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	68.98	54.59	25.61	2.54	8.49
Gross Profit, 3 Yr. CAGR %	34.31	18.05	17.93	9.88	19.22
EBITDA, 3 Yr. CAGR %	25.76	5.26	46.35	23.93	49.46
EBITA, 3 Yr. CAGR %	26.4	7.26	49	25.52	53.22
EBIT, 3 Yr. CAGR %	23.81	4.61	49.31	29	56.35
Earnings From Cont. Operations, 3 Yr. CAGR %	18.05	-10.1	16.26	17.82	50.5
Net Income, 3 Yr. CAGR %	10.43	-23.72	14.62	21.62	72.43
Normalized Net Income, 3 Yr. CAGR %	6.43	-16.77	40.07	33.19	78.56
Diluted EPS Before Extra, 3 Yr. CAGR %	6.81	-24.87	13.53	21.19	71.68
Accounts Receivable, 3 Yr. CAGR %	-0.87	-0.71	11.01	0.21	-33.74
Inventory, 3 Yr. CAGR %	192.68	162.82	2.46	1.48	4.86
Net Property, Plant and Equip., 3 Yr. CAGR %	58.7	2.42	-4.35	-5.46	-18.16
Total Assets, 3 Yr. CAGR %	41.75	28.52	4.1	-1.75	-1.33
Tangible Book Value, 3 Yr. CAGR %	-14.04	11.9	-17.71	-37.91	-5.78
Common Equity, 3 Yr. CAGR %	14.24	27.99	9.71	-8.81	7.88
Cash From Operations, 3 Yr. CAGR %	76.33	56.97	-6.46	24.88	22.25
Capital Expenditures, 3 Yr. CAGR %	-21.16	3	-20.55	-39.5	-54.4
Levered Free Cash Flow, 3 Yr. CAGR %	299.58	45.77	-42.55	-8.86	29.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	300.49	49.22	-38.88	-7.89	28.84
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	54.31	43.31	37.14	34.44	17.95
Gross Profit, 5 Yr. CAGR %	50.68	22.87	19.18	17.99	21.73
EBITDA, 5 Yr. CAGR %	24.91	12.02	20.34	24.75	43.96
EBITA, 5 Yr. CAGR %	24.81	11.3	18.5	27.85	49.68
EBIT, 5 Yr. CAGR %	22.73	10.03	18.02	27.24	50.7
Earnings From Cont. Operations, 5 Yr. CAGR %	16.79	4.12	12.03	12.83	26.55
Net Income, 5 Yr. CAGR %	12.2	-5.66	9.21	10.49	26.53
Normalized Net Income, 5 Yr. CAGR %	12.04	-5.98	10.29	19.54	45.18
Diluted EPS Before Extra, 5 Yr. CAGR %	7.5	-8.92	6.43	8.94	26.57
Accounts Receivable, 5 Yr. CAGR %	18.98	18.84	10.85	-5.9	-20.92
Inventory, 5 Yr. CAGR %	90.31	81.25	100.53	89.15	-5.55
Net Property, Plant and Equip., 5 Yr. CAGR %	71.34	49.59	29.28	-4.2	-9.79
Total Assets, 5 Yr. CAGR %	43.83	31.26	25.08	15.15	0.06
Tangible Book Value, 5 Yr. CAGR %	9.77	16.46	-13.78	-20.34	-8.58
Common Equity, 5 Yr. CAGR %	25.72	24.78	12.18	9.23	6.94
Cash From Operations, 5 Yr. CAGR %	14.6	58.35	22.24	41.58	31.8
Capital Expenditures, 5 Yr. CAGR %	4.06	-18.78	-26.33	-26.54	-34.39
Levered Free Cash Flow, 5 Yr. CAGR %	33.27	53.13	52.79	33.84	8.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.67	54.13	57.69	36.28	9.24
Dividend Per Share, 5 Yr. CAGR %	-	-	10.76	-	-